ncRNA name
hsa-miR-27a-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
NF1
Cancer name
Glioma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Temozolomide
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level
Tissue resource
paraffin-embedded glioma tissues
Experiment
None
Institute
Beijing Tiantan Hospital
Country
China
Continent
Asia